Aptar Digital Health Acquires Healint To Bolster Digital Health Portfolio

Aptar Digital Health, which offers digital health solutions globally, has recently acquired Healint, a digital health company based in Singapore. According to Aptar Digital Health, the acquisition of Healint is in line with their plan to expand their portfolio in neurology and enhance their global presence in digital health implementation.

Healint has expanded its capabilities to include patient community management, patient activation, artificial intelligence (AI) based data collection and analysis, as well as digital diagnostics to facilitate patient screening and identification. Moreover, Healint's ability to conduct clinical trial at an accelerated pace and on a global scale complements Aptar Digital Health's existing solutions, providing more value to pharmaceutical customers, as per technode.

“We are excited to welcome the Healint team and expand Aptar Digital Health’s product portfolio and capabilities to clinical trial management,“With Healint, we now have the in-house expertise to cover the entire lifecycle of a drug, positioning Aptar Digital Health as a prominent leader in digital health for Central Nervous System conditions,” said Sai Shankar, President of Aptar Digital Health.

“The integration of Healint into Aptar Digital Health’s operations will commence immediately"

As per the statement, Aptar Digital Health will expand Healint’s platform to include adjacent therapeutic indications in neurology and immunology, and enhance its current offering by introducing new services such as clinical trial management tools.

“We are delighted to join the Aptar Digital Health team to better serve patients, healthcare professionals and pharmaceutical companies, “This acquisition will accelerate the development of our AI-powered precision medicine SaMD designed to augment existing treatment, thanks to unique datasets and scientific expertise,” said François Cadiou, Chief Executive Officer and Founder of Healint.